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Abstract
Group IVa cytosolic phospholipase A2 (cPLA2α) mediates GPCR-stimulated arachidonic
acid (AA) release from phosphatidylinositol 4,5-bisphosphate (PIP2) located in plasma
membranes. We previously found in superior cervical ganglion (SCG) neurons that PLA2
activity is required for voltage-independent N-type Ca2+ (N-) current inhibition by M1 musca-
rinic receptors (M1Rs). These findings are at odds with an alternative model, previously
observed for M-current inhibition, where PIP2 dissociation from channels and subsequent
metabolism by phospholipase C suffices for current inhibition. To resolve cPLA2α’s impor-
tance, we have investigated its role in mediating voltage-independent N-current inhibition
(~40%) that follows application of the muscarinic agonist oxotremorine-M (Oxo-M). Preincu-
bation with different cPLA2α antagonists or dialyzing cPLA2α antibodies into cells minimized
N-current inhibition by Oxo-M, whereas antibodies to Ca2+-independent PLA2 had no effect.
Taking a genetic approach, we found that SCG neurons from cPLA2α-/- mice exhibited little
N-current inhibition by Oxo-M, confirming a role for cPLA2α. In contrast, cPLA2α antibodies
or the absence of cPLA2α had no effect on voltage-dependent N-current inhibition by M2/
M4Rs or on M-current inhibition by M1Rs. These findings document divergent M1R signaling
mediating M-current and voltage-independent N-current inhibition. Moreover, these differ-
ences suggest that cPLA2α acts locally to metabolize PIP2 intimately associated with N- but
not M-channels. To determine cPLA2α’s functional importance more globally, we examined
action potential firing of cPLA2α+/+ and cPLA2α-/- SCG neurons, and found decreased
latency to first firing and interspike interval resulting in a doubling of firing frequency in
cPLA2α-/- neurons. These unanticipated findings identify cPLA2α as a tonic regulator of neu-
ronal membrane excitability.
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Introduction
Following stimulation of a subset of G-protein coupled receptors (GPCRs), acutely activated
group IVa cytosolic phospholipase A2 (cPLA2α) exhibits high specificity for liberating AA
from the sn-2 position of PIP2 [1–3]. cPLA2α activity promotes acute inflammatory responses
and oxidative stress associated with neurological disorders, spinal cord injuries, and stroke [4–
9]. Additionally, there is growing interest in understanding links between cPLA2α and psychi-
atric disorders (see Rapoport, 2014[10] for review). cPLA2α also participates in cellular pro-
cesses of neurons critical for normal functioning, such as synaptic plasticity [11–15] and ion
channel modulation [16–18].
Previously, we found that bath application of AA mimics the voltage-independent inhibition
of whole-cell L- and N-type Ca2+ current in superior cervical ganglion (SCG) neurons following
stimulation of a M1R signaling cascade [19–21], referred to as the slow pathway [22]. Similar
results were found for L- and N-current from recombinant CaV1.3 and CaV2.2 channels, respec-
tively [16, 23]. M1R signaling stimulates increased release of free AA from SCG neurons implicat-
ing the acute activation of a PLA2 in the slow pathway following muscarinic stimulation [19]. We
tested for this possibility and found that pharmacologically antagonizing PLA2 activity during
M1R stimulation minimized inhibition of both whole-cell L- and N-current in SCG neurons [19–
21] and recombinant N-current [23]. These findings support the notion that a particular PLA2
may participate in M1R-mediated modulation of Ca
2+ channel activity.
cPLA2α may be the PLA2 involved in slow pathway modulation of N-type Ca
2+ (N-) chan-
nels. Binding of PIP2 to L- and N-channels is necessary for normal channel opening [24, 25].
Rapid decreases in plasma membrane levels of PIP2 following activation of a voltage-stimu-
lated phosphatase (VSP), which converts PIP2 to PIP, rapamycin-induced translocation of ino-
sitol-lipid phosphatases, or M1R stimulation [24, 25], decreases channel open probability.
cPLA2α participation in PIP2 metabolism follows an initial series of steps previously described
for the slow pathway where M1Rs via Gq stimulate phospholipase C (PLC) to initiate PIP2
metabolism (see [26]). We identified cPLA2α as the particular PLA2 mediating L-current inhi-
bition using cPLA2α antibodies as functional antagonists [19]. Moreover, fatty acid release and
L-current inhibition were both lost in SCG neurons lacking cPLA2α. These findings suggest
that cPLA2α may be the PLA2 mediating N-current inhibition during M1R stimulation by
metabolizing PIP2 molecules associated with N-channels.
Our hypothesis that cPLA2α activity may be required for N-current inhibition by M1R signal-
ing is at odds with an alternative model where M1R signaling stimulates PLC, which metabolizes
PIP2 once it dissociates from an N-channel. In this latter model, there is no requirement for
cPLA2α activity [27, 28]. Consistent with a signaling pathway independent of PLA2, normal M1R
mediated N-current inhibition was observed in the perforated-patch configuration in SCG neu-
rons in the presence of pharmacological antagonism of PLA2 activity [24]. These results raise
questions concerning a role for PLA2 in mediating N-channel modulation. We applied additional
pharmacological, biochemical and genetic approaches to determine whether cPLA2α mediates N-
current as well as L-current inhibition by M1R signaling in SCG neurons. We present results
which show that cPLA2α does serve critical roles in normal neuronal functioning: mediating N-
current modulation by M1R signaling and more broadly by regulating membrane excitability.
Materials and methods
Ethical approval
All protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of
the University of Massachusetts Medical School. The IACUC specifically approved animal use
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for this study, which was carried out in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All
efforts were made to minimize animal suffering.
Acutely dissociated SCG neurons
Acutely dissociated SCG neurons were isolated following CO2 exposure and/or decapitation
from neonatal 1–3 day-old Sprague-Dawley rats (Charles River Laboratories, Wilmington,
MA) following the methods of Liu et al. (2001) and from C57BL/6J X 129/Sv mice lacking
cPLA2α (10–16 weeks old) created in the Bonventre laboratory [29] were obtained following
decapitation using the method of Liu et al. (2006). Briefly, each ganglion was removed from
the neck region, cut into several pieces, and then transferred into a 25 cm2 culture flask con-
taining 5 ml EBSS, 0.5 mg/ml trypsin (Worthington Biochemicals, Freehold, NJ), 1 mg/ml col-
lagenase D (Roche Applied Science, Indianapolis, IN), 0.1 mg/ml DNaseI (Roche Applied
Science), 3.6 g/l glucose and 10 mM HEPES. The SCG pieces were incubated at 34˚C in a 5%
CO2/95% O2 gassed, shaking water bath. After 1 hour, cell somata were dissociated from gan-
glion fragments by trituration. The dissociation was stopped by adding 5 ml of Modified
Eagle’s Medium (Gibco, Carlsbad, CA) supplemented with 10% FBS, 4 mM glutamine and 100
IU/ml pen-100 μg/ml streptomycin. Cells were pelleted by centrifuging at 500 × g for 5 min-
utes. The resulting pellet was resuspended in the supplemented DMEM. Dissociated cells from
the equivalent of 1 SCG were plated on poly-L-lysine (Sigma) coated glass coverslips and incu-
bated in Falcon 35 mm2 dishes at 37˚C in a 5% CO2 environment. Cells were used within 48
hrs of plating. To study the effects of activation of M1Rs on N-channel activity, SCG neurons
were preincubated with 500 ng/ml PTX for at least 5 hours, to remove inhibition of N-current
by activated M2/M4 muscarinic receptors coupling to the PTX-sensitive, membrane-delimited
pathway [26]. Disabling the membrane-delimited pathway isolates N-current modulation by
the M1R, PTX-insensitive, slow pathway.
Electrophysiological methods
Standard whole-cell recording methods were used following the methods of Liu et al [23, 30].
Currents and action potentials (APs) were obtained from SCG neurons, plated on poly-L-
lysine coverslips and placed in a glass-bottomed recording chamber holding approximately
25 μl of bath solution. Electrodes were pulled from borosilicate glass capillaries (Drummond
Scientific Company, Broomall, PA) and fire-polished to a tip diameter of ~1 μm. The total
pipette access resistance ranged from 2.0–2.5 MO.
For whole-cell or perforated-patch N-current recordings, cells were clamped to -90 mV and
20 ms test pulses were delivered every 4 sec. N-current amplitude was measured 15 ms after
the start of the test pulse. To test for voltage-dependent inhibition, a prepulse protocol was
used that alternated every 4 secs between a 200-ms prepulse to +80 mV (+PP) or no prepulse
(-PP). After a brief (5-msec) return to -90 mV, the membrane voltage was stepped to +10 mV
for 100 msec. M-current was elicited by holding the membrane potential at -20 mV and apply-
ing a 500-ms hyperpolarizing pulse to -60 mV every 4 sec. M-current amplitude was measured
at -60 mV from the decaying time course of deactivating current as the difference between the
average of a 10-ms segment, taken 20–30 ms into the hyperpolarizing step and the average dur-
ing the the last 50 ms of that step. For current-clamp recordings, APs were generated by inject-
ing 40–200 pA of current for either 400 or 1,000 ms. Both voltage-clamp and current-clamp
traces were recorded using an Axopatch 200A amplifier (Molecular Devices), a 1401 plus inter-
face and Signal 2.16 software (Cambridge Electronic Design (CED), England). Traces were
cPLA2α participates in M1 receptor modulation of N-current
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low-pass filtered at 5 kHz using the amplifier’s Bessel filter, digitized at 20–40 kHz and saved
on a personal computer. All recordings were made at room temperature (20–24˚C).
Recording solutions
For perforated-patch and whole-cell recordings, the same bath and internal solutions were
used. The bath solution contained (in mM): 135 N-methyl-D-glucamine (NMG)-Asp, 10 4-
(2-hydroxyethyl)-1-piperazineethane-sulfonic acid (HEPES), 20 barium acetate and 0.0005
tetrodotoxin (TTX; Sigma) (293 mOsM). The L-channel antagonist nimodipine (NMN, 1 μM)
was included in the bath to minimize the small amount of L-current present in SCG neurons
unless otherwise stated. The pipette solution contained (in mM): 123 Cs-Asp, 10 HEPES, 0.1
1,2-bis (o-Aminophenoxy) ethane-N,N,N’,N’-tetraacetic acid (BAPTA; Sigma), 5 MgCl2, 4
ATP (Sigma) and 0.4 GTP (Sigma) (264 mOsM). pH for all solutions was adjusted to 7.5. For
perforated patch recordings, a 60 mg/ml stock solution of amphotericin B (Sigma) was made
up in dimethyl sulphoxide fresh each day. Amphotericin B was added to an aliquot of pipette
solution every 2 hours for a final concentration of 0.1 mg/ml.
For measuring whole-cell M-current, the external solution contained in mM: 160 NaCl, 2.5
KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 8 glucose, 0.0005 TTX. The pH was adjusted to 7.5 with
NaOH. The internal solution contained in mM: 175 KCl, 5 HEPES, 5 MgCl2, 0.1 BAPTA, 4
ATP, 0.4 GTP. The pH was adjusted to 7.5 with KOH.
The external solution for recording APs in the current-clamp mode contained (in mM):
120 NaCl, 3 KCl, 4 MgSO4, 1 NaH2PO4, 25 NaHCO3, 2 CaCl2 (321 mOsM); the pH was
adjusted to 7.5 with NaOH. The pipette solution contained (in mM): 110 K gluconate, 30 KCl,
1 MgSO4, 1 CaCl2, 0.1 BAPTA, 10 HEPES, 4 ATP and 0.4 GTP (297 mOsM); and the pH
adjusted to 7.5 with KOH.
NMN (Sigma), oleyloxyethyl phosphorylcholine (OPC; Calbiochem, La Jolla, CA, or Bio-
mol, Plymouth Meeting, PA) and methyl arachidonoyl fluorophosphonate (MAFP; Biomol)
were prepared as stock solutions in 100% ethanol and diluted with bath solution to a final etha-
nol concentration less than 0.11%. The maximal final concentration of ethanol had no signifi-
cant effect on whole-cell currents. Stock solutions of Oxo-M (Tocris, Ellisville, MO), ω-
agatoxin IVA (ω-Aga IV; Sigma), SNX-482 (Sigma), PTX (List Biological Laboratories, Inc.,
Campbell, CA) and TTX (Sigma) were made up in double distilled water. cPLA2 (Cell Signal-
ing, Beverly, MA) and iPLA2 (Upstate, Charlottesville, VA) antibodies were diluted directly
into the pipette solution.
Statistical analysis
Data were analyzed using Patch and Signal (CED), Excel (MicroSoft, Seattle, WA) and Origin
(MicroCal, Northampton, MA) programs. Data were expressed as means ± SEM. Statistical
significance was determined by either a two-way Student’s t-test for two means or a two-tailed
paired t-test. Data were designated as significant if p< 0.05.
Results
Antagonizing PLA2 activity minimizes N-current inhibition by Oxo-M in
perforated-patch recordings
We found previously that treating SCG neurons for two minutes with the PLA2 antagonist
OPC (10 μM) minimized whole-cell N-current inhibition by Oxo-M [21]. However, Gamper
et al. [24] found that, when using the perforated-patch recording configuration, bath applica-
tion of OPC (10 μM) for two minutes prior to Oxo-M had no effect on N-current inhibition.
cPLA2α participates in M1 receptor modulation of N-current
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To determine whether technical differences between the two recording configurations could
explain the disparity in results, we tested OPC’s ability to block N-current inhibition in SCG
neurons by the slow pathway (Fig 1A) using the perforated-patch configuration. Cells were
Fig 1. PLA2 antagonists reduce N-current inhibition by Oxo-M in neonatal rat SCG neurons. (A and B)
Schematics showing the two muscarinic signaling pathways in SCG neurons along with the antagonists used that
resulted in isolation of N-current by the slow pathway. Control inhibition by 10 μM Oxo-M is illustrated in the plot of
current amplitudes vs time (C) and in the individual sweeps (D) taken from the time course of a perforated-patch
recording. NMN (1 μM) was included in the bath to block L-current. (E) Summary of effects of PLA2 antagonists on
N-current inhibition. OPC significantly reduces inhibition of perforated-patch N-current (���p� 0.0015, n = 5) and
MAFP (10 μM) significantly reduces inhibition of whole-cell N-current. ��p� 0.015, compared to inhibition by Oxo-
M alone (open bars) using a two-tailed t-test for two means (n = 6–9). The presence of OPC (10 μM) in the bath for 3
min prior to challenging cells with Oxo-M blocks N-current inhibition, illustrated in a sample time course (F) and in
individual traces (G) taken from the time course. (H) Summary of the effects of wortmannin on current inhibition by
Oxo-M (open bar) and on current recovery following washout (black bars). M-current amplitude following Oxo-M
washout does not recover. N-current inhibition is significantly different than in the absence of wortmannin (¶p� 0.05,
using a two-tailed t-test for two means when comparing to data in Fig 1E). Significant N-current recovery occurs
following washout (�p� 0.03, two-way t-test for two means) (n = 3–9). Example time course (I) and individual traces
(J) of the reversible N-current inhibition by Oxo-M in the presence of wortmannin.
https://doi.org/10.1371/journal.pone.0201322.g001
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pretreated with PTX to block the membrane-delimited pathway (Fig 1B). Under control con-
ditions, Oxo-M (10 μM) reversibly inhibited N-current 30 ± 4.3% [CON = 416 ± 33 pA; Oxo-
M = 288 ± 27 pA] (n = 10, p< 0.0003) when comparing inhibited to control current ampli-
tudes) (Fig 1C–1E). When cells were exposed to OPC for 2 minutes, Oxo-M inhibited N-cur-
rent by 19% (n = 2), suggesting incomplete antagonism of PLA2. Therefore we increased the
pre-incubation time to 3 minutes and now found minimal (4.3±1.1%, n = 5) N-current inhibi-
tion by Oxo-M (Fig 1E–1G), similar to OPC’s actions observed previously in the whole-cell
configuration [21]. These results reproduce the findings of Gamper et al [24] and demonstrate
that a longer preincubation time with OPC is necessary, when recording in the perforated-
patch configuration, in order to observe antagonism of slow pathway modulation of N-
current.
PLA2 participates in muscarinic inhibition of whole-cell Ca
2+ current in
cortical neurons
To investigate how widespread is PLA2’s involvement in muscarinic modulation of voltage-
gated Ca2+ channel activity, we tested whether Oxo-M inhibits whole-cell Ca2+ currents of pre-
frontal cortex (PFC) pyramidal neurons (S1 Methods and S1 Fig). These neurons receive
muscarinic input from the nucleus basalis and express M1Rs [31]. Oxo-M inhibited whole-cell
currents by 35 ± 11% (n = 2). We then investigated whether antagonizing PLA2 minimizes cur-
rent inhibition and found that in the presence of OPC, Oxo-M no longer inhibited the whole-
cell current (-0.3 ± 7.2%; n = 3). These results suggest that PLA2 participates in M1R-induced
Ca2+ current inhibition in central neurons as well as peripheral sympathetic neurons. Thus,
these OPC experiments are consistent with a role for PLA2 in N-current inhibition and that its
participation in Ca2+ current modulation may be widespread.
M- and N-current modulation by M1Rs exhibit different pharmacological
sensitivities
In addition to L- and N-current inhibition by M1R signaling, the KCNQ2/3 channel current,
M-current, is inhibited by M1R signaling via decreased PIP2 levels in the membrane by a path-
way that appears independent of PLA2 [19, 32–34]. Consistent with these findings, we previ-
ously found that OPC had no effect on whole-cell native M-current inhibition [19]. Thus, we
have used M-current modulation by M1R signaling as a negative control for selective N-chan-
nel modulation by PLA2. In so doing we have identified pharmacological differences in inhibi-
tion of these two channels. In addition to a different sensitivity to OPC, a salient feature of M-
current is its irreversibility when PIP2 resynthesis is blocked by wortmannin in whole-cell and
perforated-patch configurations [24, 32]. Wortmannin is a mixed action antagonist that when
used at high concentrations (50 μM) inhibits PI4K activity thus limiting synthesis of PIP2 [35],
but has no effect on basal M-current amplitude or the magnitude of M-current inhibition by
Oxo-M.
We compared the effects of wortmannin, on whole-cell M- versus N-current inhibition by
Oxo-M to test for further differences in the properties of their respective signaling cascades.
When present in the bath solution, 50 μM wortmannin resulted in rapid run down of N-cur-
rent. However, a lower concentration of wortmannin (10 μM) blocked washout of the musca-
rinic effect for M-current (Fig 1H), similar to what had been observed previously at higher
concentrations [32]. Therefore, we tested the effects of this lower concentration of wortman-
nin on N-current inhibition. We found that the magnitude of N-current inhibition by Oxo-M
was significantly less when 10 μM wortmannin was introduced into the bath solution at least 2
min before exposing SCG neurons to Oxo-M (p� 0.01; n = 3-7/group). Under these
cPLA2α participates in M1 receptor modulation of N-current
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conditions, inhibition reversed upon washout of Oxo-M (Fig 1H–1J), similar to wortmannin’s
actions on L-current inhibition by Oxo-M [19]. Our findings with a lower wortmannin con-
centration differ from previous studies of older SCG neurons treated with higher concentra-
tions [24, 36]. Nevertheless, these results are consistent with the possibility that M- and N-
current inhibition by M1R signaling is mediated by diverging signal transduction cascades.
In addition to differences in the effects of OPC and wortmannin, we found that including
BSA in the bath solution blocks N-current inhibition by M1R signaling [37], whereas M-cur-
rent inhibition by Oxo-M remained robust (p� 0.00015) in the presence of BSA (445 ± 110
pA in the presence of BSA, 160.9 ± 47.8 pA in the presence of BSA+Oxo-M; n = 7). However,
while these experiments suggest differences in signaling, they do not identify whether one key
difference is the participation of cPLA2α in N-current but not M-current inhibition.
Identification of cPLA2α as the specific PLA2 participating in N-current
inhibition
Our previous studies demonstrated that L-current inhibition by M1Rs specifically required
cPLA2α, suggesting that it may also mediate N-current modulation [19]. To test this possibil-
ity, we examined whether MAFP, an irreversible antagonist that exhibits selectivity for cPLA2α
[38], blocks N-current inhibition. Preincubation with MAFP (10 μM) for 4 minutes resulted in
less N-current inhibition by Oxo-M (22.3 ± 7.5%; n = 9) compared to the control group
(29 ± 5.8%, n = 6), consistent with a role for cPLA2 in the pathway (Fig 1E). However, MAFP
alone significantly inhibited N-current by 29 ± 18% (p� 0.001; n = 9), raising concern about
nonspecific effects on N-channels.
Therefore, we took a more specific biochemical approach to identify the PLA2 participating
in the slow pathway by using selective antibodies as functional antagonists (Fig 2A). When an
Ab to cPLA2α (1:500) was dialyzed into SCG neurons for at least 5 minutes, Oxo-M inhibited
N-current 11 ± 2.7% (n = 8; Fig 2B and 2C). In contrast, Oxo-M elicited normal N-current
inhibition of 41 ± 7.0% (n = 4), when Abs to iPLA2 (1:200) were dialyzed into cells (Fig 2B and
2C). Basal current levels in cells dialyzed with cPLA2α Ab (371 ± 62 pA) compared to those
dialyzed with iPLA2 Ab (536 ± 156 pA) did not differ significantly (p� 0.3), indicating that
the antibodies had no effect of their own on N-current amplitude. Moreover, we previously
found that dialyzing SCG neurons with IgG also had no effect on N-current inhibition by
Oxo-M [20] reporting an average inhibition of 35.4 ± 3.4%.
To examine selectivity for M1R-mediated N-current inhibition, we tested whether the
cPLA2α Ab had any effect on N-current inhibition by M2/M4Rs. As with the OPC experi-
ments, the Ab experiments were performed with PTX-treated cells. In order to invoke simulta-
neously both M2/M4R voltage-dependent and M1R voltage-independent N-current inhibition
(Fig 2B), we continued to use a pipette solution containing a low BAPTA (0.1 mM) concentra-
tion, but eliminated neuron preincubation with PTX (Fig 2D). The two forms of inhibition
can be distinguished using a prepulse voltage protocol [39] that was initiated immediately fol-
lowing breakthrough (see methods for further details). Under these conditions, a small facilita-
tion of the whole-cell N-current was observed following a prepulse (Fig 2E and 2F) most likely
due to tonic N-current inhibition by Gβγ [20]. Upon exposure to Oxo-M, N-current was
robustly inhibited. Inhibition was partially reversed with a prepulse, revealing the amount of
M2/M4R mediated voltage-dependent inhibition. The remaining voltage-independent N-cur-
rent inhibition in SCG neurons is known to be mediated by M1R signaling [40, 41]. However,
when neurons were dialyzed with the cPLA2α Ab, prepulses now relieved all of the inhibition
by Oxo-M, consistent with inhibition occurring solely via the M2/M4R mediated voltage-
dependent pathway and little to none by the M1R voltage-independent pathway (Fig 2F).
cPLA2α participates in M1 receptor modulation of N-current
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These findings complement the OPC results and are consistent with the cPLA2α Ab selectively
preventing M1R signaling.
Previous OPC experiments suggested that M-current inhibition by M1R signaling occurs
independently of cPLA2α activity [19]. Therefore, we hypothesized that while the cPLA2α Ab
selectively prevented N-current inhibition by M1R signaling, it would have no effect on M-
Fig 2. cPLA2α is required for inhibition of whole-cell N-current by Oxo-M in SCG neurons. (A) Schematic of
experimental conditions. (B) Individual traces illustrating that dialyzing SCG neurons with cPLA2α Abs (Abs, 1:500)
minimizes N-current inhibition (n = 8) compared to robust current inhibition (41.2 ± 7.02%) of neurons dialyzed with
iPLA2 Abs (1:200; n = 4). (C) Summary bar graph illustrating the significant difference (
���p� 0.001) between the
average current inhibition with cPLA2α versus iPLA2 Abs (n = 4-8/group). (D) Schematic of membrane-delimited
pathway. (E) Individual traces showing N-current inhibition by Oxo-M (red traces) in cells dialyzed with Ab in the
absence (-PP) or following (+PP) a prepulse. (F) Summary bar graph of control (open bars) and Ox-M inhibited (red
bars) N-current amplitude with -PP or +PP protocols. Following Oxo-M, significant inhibition (�p� 0.05; n = 5)
occurred in the absence of a prepulse (-PP), which was completely relieved (��p� 0.005; n = 5/group) with a prepulse
(+PP). (G) Schematic showing the cPLA2α Ab should not affect M-current inhibition by Oxo-M. (H) Example time
course showing rapid, reversible M-current inhibition in SCG neurons dialyzed with Ab. (I) Summary bar graph
showing significant (���p� 0.0005; n = 8) M-current inhibition by Oxo-M.
https://doi.org/10.1371/journal.pone.0201322.g002
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current modulation. We tested this prediction by using the same dialysis protocol as used with
N-current modulation (Fig 2G). As predicted, robust M-current inhibition by Oxo-M was
observed in SCG neurons dialyzed with the cPLA2α Ab (Fig 2H and 2I). Taken together these
studies suggest that M- and N-current are modulated by diverging signal transduction path-
ways where N-current but not M-current inhibition requires active cPLA2α.
N-channels in cPLA2α-/- SCG neurons are resistant to modulation by the
slow pathway
Lastly, we took a genetic approach to verify a requirement for cPLA2α by testing the effect of
Oxo-M on whole-cell N-current in SCG neurons isolated from C57BL/6J x SV-129 mice lack-
ing cPLA2α [29]. The cPLA2α
+/+ C57BL/6J and SV129 mouse strains have a naturally occur-
ring background mutation in Group IIa PLA2 (sPLA2) resulting in a loss of sPLA2 activity [42,
43]. Consequently, mice lacking cPLA2α are double mutant, but for simplicity are referred to
as cPLA2α
-/- mice. Whole-cell N-currents were recorded from SCG neurons isolated from
cPLA2α
-/- mice (10–16 weeks) and compared to currents from conspecific cPLA2α
+/+ litter-
mates. Mouse SCG neurons express multiple voltage-gated Ca2+ channels [19, 44]. Therefore
to isolate N-current, a pharmacological strategy previously developed to isolate specific Ca2+
currents from mouse SCG neurons was employed [19]. Neurons were pre-incubated with ω-
Aga IVa (200 nM) for at least 30 min to irreversibly block any P/Q-type Ca2+ current. Record-
ings were completed within 20 min of the preincubation period. NMN (1 μM) and SNX-482
(20 nM) were added to the bath solution to block L- and R-type Ca2+ channels, respectively
(Fig 3A). Under these conditions, Oxo-M inhibited N-current by 42 ± 4.7% (n = 5) in
cPLA2α
+/+ SCG neurons, but only 9.5 ± 4.7% (n = 5) in cPLA2α-/- neurons (Fig 3B–3D). The
magnitude of N-current inhibition by Oxo-M differed significantly between cPLA2α
+/+ and
cPLA2α
-/- SCG neurons (p� 0.0015; n = 5). However, unstimulated whole-cell N-current
amplitude of cPLA2α
+/+ (851 ± 158 pA) and cPLA2α-/- SCG (698 ± 104 pA) neurons did not
differ (p� 0.35; n = 5 neurons/group), indicating no obvious change in control channel activ-
ity in the absence of cPLA2α (Fig 3E).
To test the extent of disrupted muscarinic signaling in the cPLA2α
-/- SCG neurons, we per-
formed two additional experiments. First, we eliminated the PTX preincubation step and
tested cPLA2α
-/- SCG neurons for N-current inhibition by M2/M4Rs. Under these conditions,
Oxo-M now significantly inhibited N-current by 40.5 ± 4.08% (p� 0.00005, n = 10), indicating
that the absence of cPLA2α had no effect on a different muscarinic signal transduction path-
way (Fig 3F). Second, we tested for differences in M-current between cPLA2α
+/+ and
cPLA2α
-/- SCG neurons, and found virtually identical average control and inhibited current
amplitudes (Fig 4) indicating that cPLA2α plays no role in regulating basal or modulated chan-
nel activity. Additionally, the magnitude of M-current inhibition following Oxo-M of
cPLA2α
+/+ (50.6 ± 6.2%) and cPLA2α-/- (57.2 ± 3.7%) SCG neurons was not significant
(p� 0.4; n = 13-14/group). These latter findings provide strong support for a model where
M1R signaling inhibits N-current by a transduction pathway that requires active cPLA2α, by
diverging from the pathway mediating M-current inhibition modulation.
cPLA2α regulates action potential firing
Many plasma membrane ion channels are affected by interactions with phospholipids and
their breakdown products. Therefore, to investigate whether cPLA2α
-/- SCG neurons exhibit
altered electrical properties, we examined the AP firing properties of cPLA2α
+/+ and cPLA2α
-/-
SCG neurons in the absence and presence of Oxo-M. Fig 5A and 5B illustrate increased rates
of firing in both types of neurons following exposure to Oxo-M. The difference in firing rate
cPLA2α participates in M1 receptor modulation of N-current
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Fig 3. Oxo-M elicits reduced N-current inhibition in cPLA2α
-\- SCG neurons. (A) Schematic of conditions used to
isolate N-current in mouse SCG neurons. Cells were preincubated in PTX at least 5 hours prior to recording. (B)
Summary bar graph of average N-current inhibition by Oxo-M in cPLA2α
-\- and cPLA2α
+\+ SCG neurons.
��p� 0.0015, cPLA2α-\- % inhibition compared to cPLA2α+\+ % inhibition using a two-tailed, t-test for two means
cPLA2α participates in M1 receptor modulation of N-current
PLOS ONE | https://doi.org/10.1371/journal.pone.0201322 December 17, 2018 10 / 22
was maintained with increasing amounts of injected current. Maximal firing rate occurred
with 100 pA of injected current (Fig 5C and 5D). While cPLA2α
+/+ and cPLA2α
-/- neurons did
not differ in firing frequency following Oxo-M, cPLA2α
-/- neurons exhibited unanticipated,
(n = 5). Individual current traces from (C) cPLA2α
+\+ compared to (D) cPLA2α
-\- SCG neurons. Black traces, Control;
red traces, Oxo-M. (E) Summary of average whole-cell N-current amplitude (NS, p� 0.44, n = 5). (F) Summary bar
graph showing that in the absence of PTX, significant membrane-delimited N-current inhibition by Oxo-M remains in
cPLA2α
-\- SCG neurons remains (���p� 0.00005, n = 10).
https://doi.org/10.1371/journal.pone.0201322.g003
Fig 4. M-current inhibition by Oxo-M remains robust in cPLA2α
-\- SCG neurons. (A) Summary bar graph of the
average M-current inhibition in cPLA2α
+/+ (���p� 4 x10-6; n = 13) and cPLA2α-/- (���p� 6 x 10−5; n = 14) neurons
following Oxo-M. (B) Schematic of the signaling cascade inhibiting M-current. Example time courses and selected
individual traces from cPLA2α
+/+ (C-D) and cPLA2α
-/- (E-F) neurons.
https://doi.org/10.1371/journal.pone.0201322.g004
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increased firing frequency under control conditions when compared to cPLA2α
+/+ neurons
that was maintained regardless of the amount of current injected (Fig 5E and 5F); however,
these increases did not reach significance.
cPLA2α
+/+ SCG neurons normally fired several APs and then adapted despite continued
current injection. A small percentage (14%) of cells fired only 1 AP (n = 5/34 recordings). We
realized the sampling time in the prior experiment may have been too short to reveal signifi-
cant differences in firing frequencies. Indeed, when the current injection time was increased
from 400 to 1,000 msec, significant differences in basal firing frequency resulted (Fig 6A and
6B). 50% of cPLA2α
-/- neurons (11/22) fired for the duration of the 1,000 msec current injec-
tion, whereas 82% of cPLA2α
+/+ neurons (27/33) adapted and ceased firing by 750 msec. We
quantitated the underlying changes in the AP waveform (see S2 Fig) of phasic and tonic neu-
rons by plotting duration of interpulse interval (IPI) against interval number and found
Fig 5. The absence of cPLA2α alters AP firing in SCG neurons. (A-B) Examples of SCG AP firing elicited with 100
pA. Black traces, control; Red traces, 2 min after Oxo-M. (C-D) Current-frequency plots show that firing frequency
increases with Oxo-M (red circles). (E) Current-frequency plots show that cPLA2α
-/- neurons (solid circles) exhibit
slightly elevated firing frequency over cPLA2α
+/+ neurons (open circles). (F) Firing frequency of cPLA2α
-/- (solid
circles) and cPLA2α
+/+ (open circles) cells following Oxo-M.
https://doi.org/10.1371/journal.pone.0201322.g005
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shorter IPIs during control firing for cPLA2α
-/- compared to cPLA2α
+/+ neurons (Fig 6C and
6E). Moreover, the time from the trough of the after hyperpolarization (AHP) to the threshold
of the subsequent AP significantly decreased (Fig 6F). Consistent with these changes, the
latency to the first AP (first latency) occurred in approximately half the time in cPLA2α
-/- com-
pared to cPLA2α
+/+ neurons (Fig 6F). We also observed consistent small increases in both the
resting membrane potential (Fig 6G) and AP amplitude (Fig 6H) with various amounts of cur-
rent injected; however, these changes did not reach significance. Additionally, no change in
the voltage difference between the AHP and threshold of the subsequent AP, peak voltage of
the AP overshoot, and AHP amplitude were observed (Fig 6I). Lastly, we measured different
aspects of the AP duration (Fig 6J). We found no differences in spike width, duration of the
rising phase of the AP (Rise Phase), duration of the falling phase, measured either from the
peak of the AP to 1/3 of the AP’s height (Falling Phase) or from the peak of the AP to the AHP
(Peak to Trough). The observed changes resulted in a doubling of basal firing rate for
cPLA2α
-/- compared to cPLA2α
+/+ neurons as measured by the number of APs/second during
current injection of 100 pA (Fig 6E, open vs grey bars). In contrast, firing frequency of both
cPLA2α
-/- and cPLA2α
+/+ neurons increased to a similar extent following exposure to Oxo-M
(Fig 6D and 6E, red bars).
Discussion
This study examined the role of cPLA2α in regulating phospholipid association with N-chan-
nels in SCG neurons. We took a multidisciplinary approach to test an emerging model of
channel modulation where multiple phospholipases including cPLA2α act in highly specific
ways to metabolize phospholipids such as PIP2 at or near N-channels following M1R stimula-
tion. Our working model provides a high degree of selective and local control over phospho-
lipid interaction with N-channels. This is in contrast to a model where PLC activity reduces
bulk PIP2 levels in the cell membrane, which indirectly lowers phospholipid levels near N-
channels [24]. Importantly, our data reconcile previous differences surrounding the role of
cPLA2α in N-channel modulation by Gq signaling and reveal a broader role for cPLA2α in reg-
ulating membrane excitability.
The pharmacological evidence reported here supports a mechanism of modulation where
N-current inhibition by M1R stimulation requires cPLA2α in addition to PLC. Antagonizing
cPLA2α with OPC reduced N-current inhibition, recorded in the perforated-patch configura-
tion (Fig 1E and 1F). We discovered that in order to antagonize N-current inhibition by Oxo-
M, a longer pre-incubation period with OPC is required most likely due to a greater main-
tained intracellular cPLA2α concentration with the perforated-patch configuration compared
to the whole-cell configuration. The longer preincubation time may allow more OPC to cross
the plasma membrane, enter the cell, and inhibit additional cPLA2α molecules that remain
during perforated-patch recordings. Thus, we suggest that the most likely reason OPC did not
prevent N-current modulation in a previous study is due to technical differences between the
recording configurations [21, 24]. Additional antagonists of cPLA2α (AACOCF3, DEDA, and
MAFP) also reduce whole-cell N-current inhibition by Oxo-M (Fig 1; [20, 21]), documenting
that OPC’s actions are not some unusual nonspecific effect. Lastly, OPC minimizes Ca2+ cur-
rent inhibition by Oxo-M in PFC pyramidal neurons, extending the potential importance of
PLA2 in M1R signaling to central neurons (S1 Fig).
Knockout mouse studies provide genetic evidence that N-current inhibition by M1R signal-
ing requires cPLA2α by showing that cPLA2α
-/- SCG neurons exhibited little, while cPLA2α
+/+
neurons exhibited robust N-current inhibition by Oxo-M (Fig 3). This interpretation of the
data takes into account evidence that cPLA2α
-/- SCG neurons maintain normal functioning of
cPLA2α participates in M1 receptor modulation of N-current
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Fig 6. Decreases in time from AHP to threshold account for increased firing of cPLA2α
-/- SCG neurons. (A-B)
Examples of differences in AP firing during a 1 sec injection of 100 pA of current. (C) IPI is significantly shorter in
cPLA2α
-/- (solid circles) compared to cPLA2α
+/+ (open circles) cells at all intervals (�p� 0.05; n = 17–23 cells/data
point). (D) Following exposure to Oxo-M, IPI interval lengths of cPLA2α
-/- (solid circles) and cPLA2α
+/+ (open circles)
cells superimpose (n = 8–18 cells/data point). (E) cPLA2α
-/- neurons (n = 22) compared to cPLA2α
+/+ neurons (n = 34)
exhibit increased basal (open bars) frequency of firing (##p� 0.00015), but no difference in frequencies (p = 0.377)
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all other components of the slow pathway. First, no significant differences between control N-
current amplitude in cPLA2α
+/+ vs cPLA2α
-/- SCG neurons were found, showing that N-chan-
nels exhibit normal activity (Fig 3E). Second, AA inhibited whole-cell currents in cPLA2α
-/-
neurons [19], demonstrating that channel sensitivity to a lipid signaling molecule downstream
of cPLA2α remains unchanged. Complementary to these findings, imaging studies revealed
that cPLA2α
-/- neurons release less fatty acid following exposure to Oxo-M, when compared to
cPLA2α
+/+ SCG neurons, indicating diminished downstream signaling [19]. Third, no signifi-
cant differences between control M-current amplitude in cPLA2α
+/+ vs cPLA2α
-/- SCG neu-
rons were found, showing that M-channels exhibit normal activity (Fig 4A). Fourth, M-
current inhibition by Oxo-M remained robust in cPLA2α
-/- SCG neurons (Fig 4) with no sig-
nificant change in the magnitude of M-current inhibition in cPLA2α
-/- SCG neurons, indicat-
ing no change in M1Rs, Gq, or PLC, key players in the slow pathway. Fifth, the absence of
cPLA2α appears to affect only specific aspects of N-current modulation by M1Rs with no effect
on membrane-delimited M2/M4R signaling or M-current inhibition by M1R signaling. Alter-
ations in unknown components in cPLA2α
-/- neurons might account for these changes rather
than loss of cPLA2α. However, our Ab studies tested the consequences of an acute loss of
cPLA2α activity in SCG neurons. Dialyzing wild-type neurons with cPLA2α Ab prevented N-
but not M-inhibition by Oxo-M (Fig 2G–2I), consistent with the knockout findings. Further-
more, Abs to sPLA2 had no effect on N-current, demonstrating a specific action of the cPLA2α
Ab in blocking the slow pathway (Fig 2B and 2C). These additional findings favor a model
where N-current inhibition by M1Rs requires PIP2 breakdown by cPLA2α. In contrast, acti-
vated PLC is sufficient to cause M-current inhibition, revealing pathway divergence down-
stream of PLC with M- and N-current modulation by M1Rs.
PIP2 is thought to play a critical role in regulating Ca
2+ channel activity where a bound PIP2
molecule facilitates coupling of voltage-sensing to channel opening [22, 24, 25, 28]. A require-
ment for cPLA2α is compatible with the idea that PIP2 bound to N-channels is selectively
metabolized in situ by activated cPLA2α following M1R stimulation. Imaging studies docu-
ment muscarinic stimulation of PIP2 breakdown occurring with a similar time course to Ca
2+
current inhibition [24, 45]. The finding that antagonizing PLC blocks M- and N-current inhi-
bition [21, 24, 36] complements these imaging studies and demonstrates that PLC activity is
necessary for M1R modulation of both currents. However, these experiments do not provide
direct evidence that rules out a requirement for cPLA2α during N-current modulation. Indeed,
our studies document that preincubation with OPC, dialysis with a selective cPLA2α Ab, or
the absence of cPLA2α, has no effect on M-current inhibition by M1Rs. These findings are con-
sistent with a divergent signaling pathway where PIP2 dissociation from K
+ channels, followed
by breakdown by PLC, is necessary and sufficient for M-current inhibition. Minimal L- and
N-current inhibition by Oxo-M occurred under these same conditions [19, 20] suggesting that
following Oxo-M (red bars). Both cPLA2α
+/+ (���p� 6 x 10−5; n = 18) and cPLA2α-/- (��p� 0.005; n = 8) neurons
exhibit increases in firing frequency following Oxo-M. (E-J) Open bars, cPLA2α
+/+ neurons; grey bars, cPLA2α
-/-
neurons, red bars, 10 μM Oxo-M. All analyses were performed on APs elicited with 100 pA unless otherwise specified.
Properties of APs were measured from the 3rd AP of a train from 3 sequential traces and averaged for each recording.
(F) Decreased latency to first firing (�p� 0.05) and time from the trough of the AHP to threshold (�p� 0.05) underlie
the changes in IPI (n = 25–33 cells/group). (G) Resting potential and (H) AP amplitude of cPLA2α
+/+ (open bars) vs
cPLA2α
-/- (grey bars) SCG neurons were not significantly different (p> 0.05; n = 15–18) across a range of current
injections. (I) Summary of average voltage change from AHP to threshold during an 80 pA current injection (n = 17
cells/group), peak AP (n = 26–27 cells/group), and maximal after hyperpolarization (n = 26–27 cells/group). See S2 Fig
for a schematic and further details of measurements. (J) Summary of the AP duration. Spike Width, measured at½ the
AP amplitude; Rising Phase, measured at 1/3 the AP potential to the peak AP; Falling Phase, measured from the peak
AP to 1/3 the AP potential; Peak to Trough, measured from the peak AP to the AHP (n = 26–27 cells/group).
https://doi.org/10.1371/journal.pone.0201322.g006
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PIP2 metabolism by PLC is insufficient for Ca
2+ channel inhibition and consistent with a
required downstream role for cPLA2α.
The requirement for additional phospholipases would protect N-channels from local Ca2+
influx chronically activating PLC to metabolize PIP2. Loss of PIP2 would stabilize channels in
the closed state. These differences in M- versus N-current modulation by the slow pathway
raise further intriguing questions about how different phospholipases might reside in channel
microdomains or show varied affinities for different types of channels. These differences
would impact which signaling molecules are generated locally to uniquely modulate N-chan-
nel activity. Recent evidence suggests that in addition to PIP2, other anionic phospholipids
such as phosphatidylserine may bind specific sites on Ca2+ channel subunits that also may reg-
ulate and participate in channel modulation [46, 47]. From the same start point (e.g., a phos-
pholipid molecule bound to an M- or N-channel), varied channel activity could occur as a
result of phospholipid metabolism by different phospholipases. Thus, from moment to
moment, differential phospholipase access to N-channels could give rise to varied current
modulation by M1Rs with the potential to create highly localized synaptic plasticity.
Lastly, we examined cPLA2α’s effect on membrane excitability to test for its importance
under more physiological conditions. In other SCG preparations, different subgroups of neu-
rons were distinguished based on different AP firing patterns including i) firing of just one AP
before adapting, ii) phasic firing of several AP before adapting and iii) tonic firing throughout
the current injection pulse [48–49]. The vast majority of cPLA2α
+/+ neurons exhibited phasic
bursting as illustrated in Figs 5A and 6A. No cPLA2α
+/+ neurons were tonically active and
only 5/34 neurons fired single APs before adapting. Our studies unexpectedly revealed that the
absence of cPLA2α dramatically increases AP firing in SCG neurons (Figs 5 and 6). These
findings suggest that cPLA2α acts in a similar manner on N-channel activity in all types of
mouse SCG neurons.
We interrogated the AP firing of phasic and tonically active neurons in more detail. A
reduced latency to the first AP along with a shortened period of membrane repolarization fol-
lowing the AHP, and loss of spike adaptation can account for the increased AP frequency of
firing. Resting membrane potential, threshold depolarization, AP amplitude, and AHP ampli-
tude, and spike width did not change significantly (Fig 6G–6J). In contrast, the absence of
cPLA2α had little effect on increased firing following Oxo-M most likely because the firing
rate already had reached maximal rates for SCG neurons, calculated to be 20–25 Hz [51].
Alternatively, increased SCG neuron firing that normally follows exposure to Oxo-M is attrib-
uted largely to inhibition of M-current [52], and we have shown that M-current is insensitive
to the absence of cPLA2α consistent with the similar observed firing frequencies in cPLA2α
+/+
and cPLA2α
-/- neurons (Fig 6D and 6H). Increased basal AP frequency in cPLA2α
-/- neurons
suggests that tonic cPLA2α activity normally suppresses membrane excitability in wild-type
neurons. Inward Ca2+ currents typically contribute to the duration of the AP overshoot; how-
ever, no obvious change occurred in the overshoot duration including the down slope of the
AP (Fig 6). Therefore, we suspect that in the absence of cPLA2α other channels sensitive to
membrane PIP2 levels and/or its metabolites may exhibit altered tonic activity in cPLA2α
-/-
neurons, whereas N-channels only become susceptible to the actions of cPLA2α following
muscarinic stimulation.
A large number of channels expressed by SCG neurons exhibit sensitivity to phospholipids
and their downstream metabolites. K+ channels determine the AP duration, frequency, and
ability to fire repetitively [53]. In SCG neurons, a number of K+ currents control the length of
the AHP including small Ca2+-activated K+ (SK3) currents [54, 55] and currents arising from
the Kv2 channel family [56, 57]. Many of these types of K+ channels in SCG neurons bind PIP2
[58, 59] however, not all PIP2 sensitive K
+ channels are affected by cPLA2α since we have
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shown that it has little effect on M-current. Some K+ channels, e.g., SK and BK channels are
enhanced by both PIP2 and cPLA2α’s metabolite AA [60–63]; whereas other channel activity is
enhanced by PIP2 but inhibited by AA [64]. Additionally PIP2 shifts HCN channel open prob-
ability versus test potential ~20 mV in the negative direction, increasing rates of neuronal fir-
ing [65, 66]. These channels are also present in SCG neurons [50] and therefore an increase in
their activity may participate in increasing cell firing in cPLA2α
-/- SCG neurons. Lastly, free
fatty acids, including AA, inhibit a number of different NaV channels often by promoting inac-
tivation (see N’Avanzo 2016 [67] for examples). Loss of AA release by cPLA2α from phospho-
lipids would be predicted to lower NaV channel inactivation and could underlie the long-
lasting spiking that we observed in cPLA2α
-/- SCG neurons. These examples underscore how
such varied changes in activity of multiple channel types make it virtually impossible to deter-
mine how many channel types in SCG neurons might be sensitive to cPLA2α activity and
therefore exhibit gating changes in cPLA2α
-/- SCG neurons.
Conclusions
cPLA2α participates in various neurophysiological and neuropathophysiological events,
including neurotransmitter release, long-term potentiation, membrane remodeling, neuronal
death following cerebral ischemia, neurodegeneration and apoptosis [5, 6, 68, 69]. We have
found at the cellular level, that cPLA2α participates in whole-cell N-current modulation by
M1R signaling. Our findings that AP firing frequency increases with loss of cPLA2α expression
reveals a role for tonic lipid processing in regulating membrane excitability that may underlie
some of cPLA2α’s functions at the systems level. Thus, our findings identify two new roles for
cPLA2α: mediating N-channel inhibition by M1R signaling and regulating membrane
excitability.
Supporting information
S1 Methods. Method for dissociating rat prefrontal cortical neurons. Acutely dissociated
pyramidal neurons from the prefrontal cortex (PFC) of young adult (2–4 weeks-old) Sprague–
Dawley rats were obtained by removing the anterior aspect of the cortex following decapita-
tion. Pieces were placed in DPBS at 4˚C. PFC pieces were manually dissected into smaller
pieces with a scalpel blade, and digested with papain (2 mg/ml) (Sigma) in Neurobasal-A
medium (Life Technologies) bubbled with a 95% O2/5% CO2 gas mixture at 37˚C in a shaking
water bath for 60 minutes. After enzyme treatment, tissues were washed with Neurobasal-A
medium containing bovine serum albumin (1 mg/ml) (Sigma) and trypsin inhibitor (1 mg/
ml) (Sigma). Tissues were transferred into Neurobasal-A medium supplemented with 20 μl/ml
of B27 (Invitrogen), 10% fetal bovine serum, 0.5 mM glutamine, and penicillin (100 U/ml)-
streptomycin (0.1 mg/ml). Cortical neurons were dissociated by gentle trituration with a fire-
polished Pasteur pipette; the supernatants after trituration were collected and mixed. Dissoci-
ated PFC neurons were then plated onto poly-L-lysine-coated glass coverslips in 25 mm2
dishes and placed at 37˚C in a CO2 (5%) humidified incubator. Cells were pretreated with
PTX for at least 5 hours before recording.
(PDF)
S1 Fig. OPC eliminates whole-cell Ca2+ current inhibition by Oxo-M recorded from disso-
ciated, large pyramidal-shaped neurons. (A) Bath application of Oxo-M (10 μM) inhibits the
whole-cell Ca2+ current from a PFC pyramidal neuron shown in the plot of current amplitude
vs time (left) and in individual sweeps (right) taken from the time course. (B) In contrast, OPC
(10 μM) blocked current inhibition shown in the plot of current amplitude vs time (left) and
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in the individual sweeps (right) taken from the time course.
(PDF)
S2 Fig. Schematic of how the different aspects of APs, presented in Fig 6C–6J, were mea-
sured. Spike Width, duration of AP at V½ of the AP amplitude. Rising Phase, time from V1/3
of AP to peak of AP. Falling Phase, time from AP peak to V1/3 of AP. Peak to Trough, time
from AP peak to AHP.
(PDF)
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